Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Rezaei, Nima  [Clear All Filters]
Journal Article
Arabpour M, Saghazadeh A, Rezaei N. Anti-inflammatory and M2 macrophage polarization-promoting effect of mesenchymal stem cell-derived exosomes. Int Immunopharmacol. 2021;97:107823.
Salmaninejad A, Zamani MReza, Pourvahedi M, Golchehre Z, Bereshneh AHosseini, Rezaei N. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers. Immunol Invest. 2016:1-22.
Jamee M, Azizi G, Baris S, Karakoc-Aydiner E, Ozen A, Kilic SS, Kose H, Chavoshzadeh Z, Mahdaviani SAlireza, Momen T, et al. Clinical, immunological, molecular and therapeutic findings in monogenic immune dysregulation diseases: Middle East and North Africa registry. Clin Immunol. 2022:109131.
Moslemizadeh A, Nematollahi MHadi, Amiresmaili S, Faramarz S, Jafari E, Khaksari M, Rezaei N, Bashiri H, Kheirandish R. Combination therapy with interferon-gamma as a potential therapeutic medicine in rat's glioblastoma: A multi-mechanism evaluation. Life Sci. 2022:120744.
Yazdani R, Abolhassani H, Kiaee F, Habibi S, Azizi G, Tavakol M, Chavoshzadeh Z, Mahdaviani SAlireza, Momen T, Gharagozlou M, et al. Comparison of Common Monogenic Defects in a Large Predominantly Antibody Deficiency Cohort. J Allergy Clin Immunol Pract. 2018.
Bayegi SNamazi, Hamidieh AAli, Behfar M, Bozorgmehr M, Saghazadeh A, Tajik N, Delbandi A-A, Zavareh FTofighi, Delavari S, Shekarabi M, et al. Disturbance in the reconstitution of distinct T-cell subsets and the incidence of GvHD following allo-HSCT in pediatric patients with non-malignant hematological disorders. Immunol Lett. 2023.
Taghavi-Farahabadi M, Mahmoudi M, Hashemi SMahmoud, Rezaei N. Evaluation of the effects of mesenchymal stem cells on neutrophils isolated from severe congenital neutropenia patients. Int Immunopharmacol. 2020;83:106463.
Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, Abdel-Rahman O, Abdelalim A, Abdoli A, Abdollahpour I, Abdulle ASM, et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2019.
Linder MI, Mizoguchi Y, Hesse S, Csaba G, Tatematsu M, Łyszkiewicz M, Ziętara N, Jeske T, Hastreiter M, Rohlfs M, et al. Human genetic defects in SRP19 and SRPRA cause severe congenital neutropenia with distinctive proteome changes. Blood. 2022.
Mansourabadi AHossein, Sadeghalvad M, Mohammadi-Motlagh H-R, Rezaei N. The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19. Life Sci. 2020:118185.
Farajifard H, Zavvar M, Rajaei T, Noorbakhsh F, Nikougoftar-Zarif M, Azadmanesh K, Kompani F, Rezaei N. In vitro study of HAX1 gene therapy by retro viral transduction as a therapeutic target in severe congenital neutropenia. Eur Cytokine Netw. 2019.
Lavafian A, Pezeshki PSadat, Rezaei N. Investigation of the female infertility risk associated with anti-cancer therapy. Clin Transl Oncol. 2023.
Fekrvand S, Yazdani R, Olbrich P, Gennery A, Rosenzweig SD, Condino-Neto A, Azizi G, Rafiemanesh H, Hassanpour G, Rezaei N, et al. Primary immunodeficiency diseases and Bacillus Calmette-Guérin (BCG)-vaccine-derived complications: a systematic review. J Allergy Clin Immunol Pract. 2020.
Sabahi M, Jabbari P, Haghighi MAlizadeh, Soltani S, Soudi S, Rahmani F, Rezaei N. Proposing a tandem AND-gate CAR T cell targeting glioblastoma multiforme. Med Hypotheses. 2020;137:109559.
Bayegi SNamazi, Hamidieh AAli, Behfar M, Saghazadeh A, Bozorgmehr M, Tajik N, Delbandi AAkbar, Delavari S, Shekarabi M, Rezaei N. The reconstitution of T-cells after Allogeneic Hematopoietic Stem Cell Transplant in a Pediatric Patient with Congenital Amegakaryocytic Thrombocytopenia (CAMT). Endocr Metab Immune Disord Drug Targets. 2023.
Basiri A, Pazhouhnia Z, Beheshtizadeh N, Hoseinpour M, Saghazadeh A, Rezaei N. Regenerative Medicine in COVID-19 Treatment: Real Opportunities and Range of Promises. Stem Cell Rev Rep. 2020.
Sharif H, Ziaei H, Rezaei N. Stem Cell-Based Regenerative Approaches for the Treatment of Cleft Lip and Palate: A Comprehensive Review. Stem Cell Rev Rep. 2024.
Pour-Rashidi A, Mohammadi E, Rezaei N, Hanaei S. Stem Cells and Targeted Gene Therapy in Brain and Spinal Cord Tumors. Adv Exp Med Biol. 2023;1394:137-152.
Bayegi SNamazi, Hamidieh AAli, Behfar M, Saghazadeh A, Bozorgmehr M, Karamlou Y, Shekarabi M, Tajik N, Delbandi A-A, Zavareh FTofighi, et al. T helper 17 and regulatory T-cell profile and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in pediatric patients with beta-thalassemia. Transpl Immunol. 2023:101803.